UVIMOX 1.2 GM Injection – A new more powerful defense against resistant bacterial infections
Amoxicillin & Potassium Clavulanate Injection – UVIMOX 1.2 GM Injection contains Amoxicillin Amoxicillin Sodium 1000mg and Clavulanic Acid 200mg,
Amoxicillin is a broad-spectrum penicillin antibiotic that inhibits bacterial cell wall synthesis, leading to bacterial cell death. However, many bacteria produce beta-lactamase enzymes, rendering amoxicillin ineffective. To combat this, potassium clavulanate, a beta-lactamase inhibitor, is added to protect amoxicillin from degradation. This combination effectively treats infections caused by beta-lactamase-producing bacteria, offering superior clinical outcomes in managing bacterial infections.
Recommended by specialist
✅Pulmonologist :- To treat Respiratory tract infections (e.g., bronchitis, pneumonia)
✅Orthopedic :- To manage Bone and joint infections
✅Urologist :- To the patients with Urinary tract infections (UTIs)
✅Dermatologist :- For treatment of Skin and soft tissue infections
Key benefits of Amoxicillin & Potassium Clavulanate Injection – UVIMOX 1.2 GM Injection
✅Enhanced Spectrum of Action : The combination of amoxicillin with potassium clavulanate effectively targets beta-lactamase-producing bacteria, covering a wide range of Gram-positive and Gram-negative pathogens.
✅Effective against Resistant Strains : Potassium clavulanate neutralizes beta-lactamase enzymes, restoring amoxicillin’s efficacy against resistant bacterial strains.
✅Broad Indication Range: Ideal for respiratory, urinary, skin, and soft tissue infections, providing reliable results across diverse infections.
✅Fast Onset of Action : Injectable form ensures rapid systemic availability and rapid therapeutic action.
Indications –
✅Respiratory tract infections (e.g., bronchitis, pneumonia)
✅Skin and soft tissue infections
✅Urinary tract infections (UTIs)
✅Otitis media and sinusitis
✅Bone and joint infections
✅Dental infections